Adragos Pharma GmbH, based in Munich, operates as a holding company with a business purpose focused on managing its own assets and providing management and service functions to its subsidiaries. The company employs an average of 20 staff members. The balance sheet total increased significantly in the 2023 fiscal year to approximately 113.2 million euros, primarily driven by the expansion of financial assets. The company is registered in the Munich commercial register under the number HRB 274699. The company is a small company under § 267 (1) HGB and is therefore not required to publish a profit-and-loss statement.
Verwaltung eigenen Vermögens sowie Erbringen von Management- und Servicedienstleistungen an Tochtergesellschaften gegen Entgelt, ausgenommen erlaubnispflichtige Tätigkeiten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 274699 (as of 4 November 2026)
| Name | Type | City |
|---|---|---|
| Andreas Raabe | Geschäftsführer(in) | München |
| Daniel Wigbers | Geschäftsführer(in) | Berlin |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 274699 (as of 4 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | ≤ €15M1 | — | €127,921,038 | — |
| 2023 | ≤ €15M1 | — | €113,197,377 | 20 |
| 2022 | ≤ €12M1 | €209,321 | €73,419,420 | 19 |
| 2021 | ≤ €12M1 | -€3,710,296 | €67,061,382 | 7 |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 274699 (as of 4 November 2026)
